Human versus mouse PD-1

被引：0
|
作者：
Staicu, Ioana
机构：
[1] Nature Immunology,
来源：
NATURE IMMUNOLOGY | 2025年 / 26卷 / 02期
关键词：
D O I：
10.1038/s41590-025-02086-x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] Soluble PD-1 (sPD-1) is expressed in human macrophages
    Antonsen, Kristian W.
    Hviid, Claus V. B.
    Hagensen, Mette K.
    Sorensen, Boe S.
    Moller, Holger J.
    CELLULAR IMMUNOLOGY, 2021, 369
  • [42] Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters
    Nishi, Wataru
    Wakamatsu, Ei
    Machiyama, Hiroaki
    Matsushima, Ryohei
    Saito, Kensho
    Yoshida, Yosuke
    Nishikawa, Tetsushi
    Takehara, Tomohiro
    Toyota, Hiroko
    Furuhata, Masae
    Nishijima, Hitoshi
    Takeuchi, Arata
    Azuma, Miyuki
    Suzuki, Makoto
    Yokosuka, Tadashi
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [43] The cellular basis of the PD-1/PD-L1 regulatory pathway in diabetic autoimmunity in the NOD mouse
    Hu, Hao
    Wan, Xiaoxiao
    Zakharov, Pavel
    Unanue, Emil R.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [44] The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells
    Huang, Bo Yuan
    Zhan, Yi Ping
    Zong, Wen Jing
    Yu, Chun Jiang
    Li, Jun Fa
    Qu, Yan Ming
    Han, Song
    PLOS ONE, 2015, 10 (08):
  • [45] PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib
    Xu, Yongkang
    Fu, Shumin
    Shang, Kai
    Zeng, Jiayu
    Mao, Ye
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%
    Sezer, A.
    Gogishvili, M.
    Bentsion, D.
    Kilickap, S.
    Lowczak, A.
    Gumus, M.
    Gladkov, O.
    Clingan, P.
    Sriuranpong, V.
    Rizvi, N.
    Lee, S.
    Li, S.
    Snodgrass, P.
    Navarro, M.
    Lowy, I.
    Rietschel, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S638 - S638
  • [47] ENTPD1 and PD-1/PD-1 ligands are highly expressed by skin-resident immune cells in subsets of human SCC
    McCray, C.
    Cook, J.
    Streilein, R.
    Degan, S.
    Havran, W.
    Zhang, J. Y.
    MacLeod, A. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S7 - S7
  • [48] PD-1 Signals Murine and Human Treg for Enhanced Migration
    Piao, W.
    Xiong, Y.
    Li, L.
    Hippen, K.
    Zhang, Y.
    Saxena, V.
    Paluskievicz, C.
    WillsonShirkey, M.
    Blazar, B.
    Riella, L.
    Bromberg, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 744 - 744
  • [49] Inherited human PD-1 deficiency underlies tuberculosis and autoimmunity
    Ogishi, Masato
    Yang, Rui
    Aytekin, Caner
    Boisson-Dupuis, Stephanie
    Casanova, Jean-Laurent
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [50] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
12345